• High Levels of Iron During Therapy Linked to Residual Gaucher Disease, Study Finds
  • Gaucher Disease Guidance Could Help Non-specialists Diagnosis It Better, Study Reports
  • Nerve Cell Damage Causes Pain in Gaucher Disease Type 1 Patients, Italian Study Suggests
  • Three Newly Identify Compounds Show Promise for Types 2 and 3 Gaucher Disease
  • Accordant’s Gaucher Program Receives NCQA Disease Management Accreditation
  • Cerdelga Trial Extension Confirms Improvements in Gaucher Type 1 Patients
  • Gaucher Patients Have Mixed Views About Substrate Reduction Therapies, Study Finds
  • UK Clinical Trial Aims to Characterize Symptoms and Therapy Response in Gaucher Types 1 and 3
  • Newborn Screening Platform for Lysosomal Storage Diseases Granted CE Mark in Europe
  • Poor Bone Health in Gaucher Disease May Be Unrelated to the Condition Itself, Study Reports
  • Long-term Follow-up Needed to Assess Newborn Screening for Lysomal Storage Disorders
  • Sanofi Genzyme Planning Next Round of Scholarships for Students with Lysosomal Storage Disorders